IMP3 can also enhance p65 expression and activate the NF-κB signaling pathway by specifically binding to sites on the p65 mRNA 3'UTR, which in turn promotes metastatic migration of glioma cells [126]. Here, NFKB1 is linked to central nervous system cancer.